Article
Transcriptional analysis of doxorubicin-induced cardiotoxicity
26 Oct 2005
Abstract excerpt
Doxorubicin is an effective chemotherapeutic agent against a broad range of tumors. However, a threshold dose of doxorubicin causes an unacceptably high incidence of heart failure and limits its clinical utility. We have established two models of doxorubicin cardiotoxicity in mice: 1) in an acute model, mice are treated with 15 mg/kg of doxorubicin once; and 2) in a chronic model, they receive 3 mg/kg weekly for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
